Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Lung Cancer 2010 NHLBI 5R03HL097016-02 Genetic Role of EGFR pathway in Interstitial Lung Disease LIU, WANQING UNIVERSITY OF CHICAGO IL $78,000
Lung Cancer 2010 NCI 5R01CA136851-02 EML4-ALK: A Potential Therapeutic Target in Lung Cancer JANNE, PASI DANA-FARBER CANCER INSTITUTE MA $361,984
Lung Cancer 2010 NCI 5R01CA081436-13 Protein Kinase C Signaling Mechanisms in Cancer FIELDS, ALAN MAYO CLINIC JACKSONVILLE FL $438,109
Lung Cancer 2010 NCI 5R01CA103618-18 Role of cPLA2 in Lung Cancer: Microenvironment vs Tumor Cells NEMENOFF, RAPHAEL UNIVERSITY OF COLORADO DENVER CO $280,917
Lung Cancer 2010 NIEHS 5R21ES017353-02 Polymorphic variants of human DNA glycosylase NEIL2 and lung cancer susceptibilit HAZRA, TAPAS UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $210,693
Lung Cancer 2010 NCI 5R01CA094121-07 Promotion of angiogenesis in lung cancer by MIF ARENBERG, DOUGLAS UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $276,601
Lung Cancer 2010 NCI 5R01CA137195-02 Characterization and drug targeting of the PML tumor suppressor in lung cancer SCAGLIONI, PIER UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $325,775
Lung Cancer 2010 NCI 5R01CA132844-02 ROLE OF CYP24 IN NON-SMALL CELL LUNG CANCER HERSHBERGER, PAMELA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $282,925
Lung Cancer 2010 NCI 5R03CA139584-02 Compliance With Lung Cancer Screening GAREEN, ILANA BROWN UNIVERSITY RI $80,979
Lung Cancer 2010 NCI 5R01CA129562-02 Identification of Novel Kras Effector Pathways in Lung Cancer SWEET-CORDERO, ERIC STANFORD UNIVERSITY CA $272,150
Lung Cancer 2010 NCI 5R01CA104397-07 Role of IKK in NSCLC: Modulation of SMRT and NF-kappaB MAYO, MARTY UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $278,392
Lung Cancer 2010 NCI 5R21CA135605-02 A phase Ib/II study of AZD2171 and radiation for new brain metastases from NSCLC EICHLER, APRIL MASSACHUSETTS GENERAL HOSPITAL MA $1
Lung Cancer 2010 NCI 5R01CA075954-13 Mechanism of Dnmt1 Up-regulation by Fhit Loss BRENNER, CHARLES UNIVERSITY OF IOWA IA $273,966
Lung Cancer 2010 NCI 5R01CA139612-02 Role of Id1 in NSCLC Progression and Metastasis CHELLAPPAN, SRIKUMAR H. LEE MOFFITT CANCER CTR & RES INST FL $345,576
Lung Cancer 2010 NIEHS 5R21ES017145-02 ADSS1 inactivation as a promoter of tumor metabolism and lung carcinogenesis HERZOG, CHRISTOPHER PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $191,307
Lung Cancer 2010 NCI 5R21CA135335-02 Prevention of Lung Tumors by Agents using Concurrent and Sequential Treatment PEREIRA, MICHAEL OHIO STATE UNIVERSITY OH $132,000
Lung Cancer 2010 NCI 5R01CA138841-02 SWI/SNF complex loss facilitates gene silencing during NSCLC development WEISSMAN, BERNARD UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $307,100
Lung Cancer 2010 NCI 5R01CA140594-02 Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer WONG, KWOK KIN DANA-FARBER CANCER INSTITUTE MA $476,188
Lung Cancer 2010 NCI 5R01CA131327-02 Validation and extension of an existing risk model for lung cancer ETZEL, CAROL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $615,470
Lung Cancer 2010 NCI 5R01CA136530-02 Refining and Validating Genomic Signatures in Lung Cancer WILLARD, HUNTINGTON DUKE UNIVERSITY NC $323,700
Lung Cancer 2010 NCI 5R01CA092596-07 Human CYP2A and respiratory tract xenobiotic toxicity DING, XINXIN WADSWORTH CENTER NY $333,739
Lung Cancer 2010 NCI 5R01CA137037-03 lung tumor exosome-mediated inflammation promotes tumor progression and growth ZHANG, HUANG-GE UNIVERSITY OF LOUISVILLE KY $308,405
Lung Cancer 2010 NIGMS 5R01GM084959-02 Intracellular Domain Elements in the Regulation of EGF Receptor Kinase Activity CARPENTER, GRAHAM VANDERBILT UNIVERSITY TN $384,958
Lung Cancer 2010 OD 5RC1CA144640-02 Modulation of cancer prevention by social stress SCHULLER, HILDEGARD UNIVERSITY OF TENNESSEE KNOXVILLE TN $500,000
Lung Cancer 2010 NIDA 5RC2DA028955-02 Mice with Functional Fluorescent Nicotinic Receptor Subunits LESTER, HENRY CALIFORNIA INSTITUTE OF TECHNOLOGY CA $966,896
Lung Cancer 2010 OD 1R15CA150999-01 PILOT: Home Telemonitoring for Self Management Education of Patients with Lung Ca NARSAVAGE, GEORGIA WEST VIRGINIA UNIVERSITY WV $366,250
Lung Cancer 2010 NCI 5RC1CA145422-02 Early Functional Genetic and Epigenetic Changes in Human Lung Carcinogenesis SPIVACK, SIMON ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $499,186
Lung Cancer 2010 NCI 5RC1CA146260-02 Polymorphism and mutation spectrum in minorities with non-small cell lung cancer CARBONE, DAVID VANDERBILT UNIVERSITY TN $497,012
Lung Cancer 2010 NCI 5RC1CA146843-02 A novel molecular diagnostic approach to classify lung cancers and predict respon MAYER, BRUCE UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $489,074
Lung Cancer 2010 NCI 5RC2CA148265-02 Nanotechnology for Multiplexed and Intraoperative Cancer Detection NIE, SHUMING EMORY UNIVERSITY GA $508,781
Lung Cancer 2010 OD 5RC2CA148265-02 Nanotechnology for Multiplexed and Intraoperative Cancer Detection NIE, SHUMING EMORY UNIVERSITY GA $508,780
Lung Cancer 2010 NCI 5RC2CA148302-02 Loss of miR-29s as predictor of response to demethylating agents CROCE, CARLO OHIO STATE UNIVERSITY OH $2,026,079
Lung Cancer 2010 NCI 5RC2CA147940-02 The Co-Clinical Project: Informing clinical trials using preclinical mouse models PANDOLFI, PIER PAOLO BETH ISRAEL DEACONESS MEDICAL CENTER MA $2,088,292
Lung Cancer 2010 NCI 5RC2CA148225-02 A Concerted Attack on Patient Specific Oncogenic Vulnerabilities in Lung Cancer ROTH, MICHAEL UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $1,644,663
Lung Cancer 2010 NCI 5RC2CA148394-02 Lung Cancer Mutation Analysis BUNN, PAUL UNIVERSITY OF COLORADO DENVER CO $1,172,626
Lung Cancer 2010 OD 5RC2CA148394-02 Lung Cancer Mutation Analysis BUNN, PAUL UNIVERSITY OF COLORADO DENVER CO $1,172,624
Lung Cancer 2010 NCI 5RC2CA148572-02 Validation of a multi-gene test for lung cancer risk WILLEY, JAMES UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $850,365
Lung Cancer 2010 NIEHS 3R01ES016893-02S2 Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts WISE, JOHN UNIVERSITY OF SOUTHERN MAINE ME $76,209
Lung Cancer 2010 NIEHS 3R21ES017307-01A1S1 Allergic asthma and chromium exposure CONSTANT, STEPHANIE GEORGE WASHINGTON UNIVERSITY DC $12,224
Lung Cancer 2010 NIEHS 3R01ES015662-03S1 Mutagenesis of p53 by reactive PAH and ROS FIELD, JEFFREY UNIVERSITY OF PENNSYLVANIA PA $7,196
Lung Cancer 2010 NIEHS 7R21ES017237-03 Analysis of arsenic in inducing ROS, signaling pathways, and lung carcinogenesis JIANG, BING-HUA THOMAS JEFFERSON UNIVERSITY PA $232,000
Lung Cancer 2010 NCI 5P01CA136396-02 5238 Early Stage Lung Cancer KERNSTINE, KEMP CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $617,876
Lung Cancer 2010 NCI 5P01CA136396-02 5239 Late Stage Lung Cancer FIGLIN, ROBERT CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $657,540
Lung Cancer 2010 NCI 5P01CA136396-02 5240 Family Caregivers GRANT, MARCIA CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $662,985
Lung Cancer 2010 NCI 5P01CA136396-02 5241 Administrative FERRELL, BETTY CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $85,917
Lung Cancer 2010 NCI 5P01CA136396-02 5242 Biostatistics GRANT, MARCIA CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $125,415
Lung Cancer 2010 NCI 5P01CA136396-02 5243 Geriatric HURRIA, ARTI CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $69,122


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer